AstraZeneca plc’s Buy Rating Reaffirmed at Citigroup Inc. (AZN)
AstraZeneca plc (LON:AZN) traded up 0.59% on Friday, hitting GBX 4470.00. The stock had a trading volume of 4,340,777 shares. AstraZeneca plc has a 1-year low of GBX 3028.50 and a 1-year high of GBX 5750.00. The stock’s 50-day moving average is GBX 4463.31 and its 200-day moving average is GBX 4002.. The company’s market cap is £56.367 billion.
A number of other firms have also recently commented on AZN. Analysts at Jefferies Group reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Thursday. They now have a GBX 4,120 ($69.94) price target on the stock. Separately, analysts at Sanford C. Bernstein reiterated a “market perform” rating on shares of AstraZeneca plc in a research note on Wednesday. They now have a GBX 4,400 ($74.69) price target on the stock. Finally, analysts at Beaufort Securities reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Monday. Seven analysts have rated the stock with a sell rating, fifteen have issued a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of GBX 3,926.24 ($66.65).
AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.